AAAAAA
Results: 1-25/53
Authors:
HOLST J
KRISTENSEN TA
KRISTENSEN HI
EZBAN M
HEDNER U
Citation: J. Holst et al., LOCAL APPLICATION OF RECOMBINANT ACTIVE-SITE INHIBITED HUMAN CLOTTINGFACTOR VIIA REDUCES THROMBUS WEIGHT AND IMPROVES PATENCY IN A RABBIT VENOUS THROMBOSIS MODEL, European journal of vascular and endovascular surgery, 15(6), 1998, pp. 515-520
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECTS OF ACTIVATED FACTOR-VII IN A CELL-BASED MODEL FOR TISSUE FACTOR-INITIATED COAGULATION, Blood coagulation & fibrinolysis, 9, 1998, pp. 21-25
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., ACTIVE SITE-INACTIVATED FACTORS VIIA, XA, AND IXA INHIBIT INDIVIDUAL STEPS IN A CELL-BASED MODEL OF TISSUE FACTOR-INITIATED COAGULATION, Thrombosis and haemostasis, 80(4), 1998, pp. 578-584
Authors:
POULSEN LK
JACOBSEN N
SORENSEN BB
BERGENHEM NCH
KELLY JD
FOSTER DC
THASTRUP O
EZBAN M
PETERSEN LC
Citation: Lk. Poulsen et al., SIGNAL-TRANSDUCTION VIA THE MITOGEN-ACTIVATED PROTEIN-KINASE PATHWAY INDUCED BY BINDING OF COAGULATION-FACTOR VIIA TO TISSUE FACTOR, The Journal of biological chemistry, 273(11), 1998, pp. 6228-6232
Authors:
GOLINO P
RAGNI M
CIRILLO P
DANDREA D
SCOGNAMIGLIO A
RAVERA A
BUONO C
EZBAN M
CORCIONE N
VIGORITO F
CONDORELLI M
CHIARIELLO M
Citation: P. Golino et al., ANTITHROMBOTIC EFFECTS OF RECOMBINANT HUMAN, ACTIVE SITE-BLOCKED FACTOR VIIA IN A RABBIT MODEL OF RECURRENT ARTERIAL THROMBOSIS, Circulation research, 82(1), 1998, pp. 39-46
Authors:
GOLINO P
CIRILLO P
DANDREA D
RAGNI M
CALABR P
RAVERA M
TOMMASINI P
EZBAN M
CHIARIELLO M
Citation: P. Golino et al., LONG-TERM ANTITHROMBOTIC EFFECTS OF HUMAN RECOMBINANT, ACTIVE SITE-BLOCKED FACTOR-VII IN A CHRONIC RABBIT MODEL OF INTRAVASCULAR THROMBOSIS, Circulation, 98(17), 1998, pp. 3814-3814
Authors:
TAYLOR FB
CHANG ACK
PEER G
LI A
EZBAN M
HEDNER U
Citation: Fb. Taylor et al., ACTIVE-SITE INHIBITED FACTOR VIIA (DEGR VIIA) ATTENUATES THE COAGULANT AND INTERLEUKIN-6 AND INTERLEUKIN-8, BUT NOT TUMOR-NECROSIS-FACTOR, RESPONSES OF THE BABOON TO LD100 ESCHERICHIA-COLI, Blood, 91(5), 1998, pp. 1609-1615
Authors:
ORVIM U
BARSTAD RM
ORNING L
PETERSEN LB
EZBAN M
HEDNER U
SAKARIASSEN KS
Citation: U. Orvim et al., ANTITHROMBOTIC EFFICACY OF INACTIVATED ACTIVE-SITE RECOMBINANT FACTORVIIA IS SHEAR DEPENDENT IN HUMAN BLOOD, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 3049-3056
Authors:
HANSEN K
KJALKE M
RASMUSSEN PB
KONGERSLEV L
EZBAN M
Citation: K. Hansen et al., PROTEOLYTIC CLEAVAGE OF RECOMBINANT 2-CHAIN FACTOR-VIII DURING CELL-CULTURE PRODUCTION IS MEDIATED BY PROTEASE(S) FROM LYSED CELLS - THE USE OF PULSE LABELING DIRECTLY IN PRODUCTION MEDIUM, Cytotechnology, 24(3), 1997, pp. 227-234
Authors:
ARNLJOTS B
EZBAN M
HEDNER U
Citation: B. Arnljots et al., PREVENTION OF EXPERIMENTAL ARTERIAL THROMBOSIS BY TOPICAL ADMINISTRATION OF ACTIVE SITE-INACTIVATED FACTOR VIIA, Journal of vascular surgery, 25(2), 1997, pp. 341-346
Authors:
KJALKE M
MONROE DM
HOFFMAN M
OLIVER JA
EZBAN M
ROBERTS HR
Citation: M. Kjalke et al., COMPARISON OF THE EFFECTS OF ACTIVE SITE-INHIBITED FACTORS VIIA, XA, AND IXA IN A CELL-BASED MODEL FOR TISSUE FACTOR INITIATED COAGULATION, Thrombosis and haemostasis, 1997, pp. 40-40
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN TREATMENT, Thrombosis and haemostasis, 1997, pp. 44-44
Authors:
KORSGAARD N
ELM T
NIELSEN LS
EZBAN M
KRISTENSEN AT
Citation: N. Korsgaard et al., TIME-COURSE OF TISSUE FACTOR PROTEIN AND MESSENGER-RNA EXPRESSION IN RABBIT ARTERIES AFTER MECHANICAL INJURY, Thrombosis and haemostasis, 1997, pp. 824-824
Authors:
NOGUCHI S
EZBAN M
WILCOX JN
Citation: S. Noguchi et al., IMMUNOHISTOCHEMICAL LOCALIZATION OF TISSUE FACTOR, FACTOR-VII, FACTOR-X, AND TISSUE FACTOR PATHWAY INHIBITOR PROTEINS IN NORMAL AND ATHEROSCLEROTIC VESSELS, Thrombosis and haemostasis, 1997, pp. 832-832
Authors:
TAYLOR FB
CHANG AC
LOCKHART M
PEER G
LI A
EZBAN M
HEDNER U
Citation: Fb. Taylor et al., ACTIVE-SITE INHIBITED FACTOR VIIA (DEGR VIIA) ATTENUATES THE COAGULANT AND INTERLEUKIN-6 AND INTERLEUKIN-8 BUT NOT TUMOR-NECROSIS-FACTOR RESPONSES OF THE BABOON TO LD100 ESCHERICHIA-COLI, Thrombosis and haemostasis, 1997, pp. 1500-1500
Authors:
SORENSEN BB
PERSSON E
FRESKGARD PO
KJALKE M
EZBAN M
WILLIAMS T
RAO LVM
Citation: Bb. Sorensen et al., INTERACTION OF ACTIVE-SITE INHIBITED FACTOR VIIA WITH, Thrombosis and haemostasis, 1997, pp. 1646-1646
Authors:
ELM T
RASMUSSEN K
EZBAN M
KRISTENSEN AT
Citation: T. Elm et al., TIME-COURSE OF INACTIVATED-RFVIIA INHIBITION OF TISSUE FACTOR-RFVIIA ACTIVITY IN A RABBIT EX-VIVO MODEL, Thrombosis and haemostasis, 1997, pp. 1652-1652
Authors:
NOGUCHI S
EZBAN M
WILCOX JN
Citation: S. Noguchi et al., LOCALIZATION OF FACTOR-VII MESSENGER-RNA IN HUMAN ATHEROSCLEROTIC PLAQUES AND EXTRAHEPATIC TISSUES, Thrombosis and haemostasis, 1997, pp. 2319-2319
Authors:
KRISTENSEN AT
EZBAN M
JAPPE MB
KORSGAARD N
ELM T
BERGENHEM NC
HEDNER U
Citation: At. Kristensen et al., CHARACTERIZATION OF FERRICHLORIDE INDUCED ARTERIAL THROMBOSIS IN RABBITS - A CONTACT SYSTEM DEPENDENT MODEL, Thrombosis and haemostasis, 1997, pp. 2346-2346
Authors:
KRISTENSEN HI
DANIELSEN A
OSTERGAARD P
EZBAN M
Citation: Hi. Kristensen et al., EFFECT OF A NEW ANTITHROMBOTIC AGENT - ACTIVE-SITE INHIBITED RECOMBINANT FACTOR-VII (FFR-RFVIIA) IN CONVENTIONAL CLOTTING ASSAYS, Thrombosis and haemostasis, 1997, pp. 2529-2529
Authors:
NICOLAISEN EM
KRISTENSEN H
KRISTENSEN AT
EZBAN M
VERLAND S
CHRISTENSEN E
HEDNER U
Citation: Em. Nicolaisen et al., ANTIGENICITY OF CHLOROMETHYL-KETONE-INACTIVATED RECOMBINANT FVIIA (CMK-RFVIIA), EVALUATED IN AN EXPERIMENTAL HUMAN FVII-IMMUNE-TOLERANT MODEL, Thrombosis and haemostasis, 1997, pp. 2804-2804
Authors:
HOLST J
KRISTENSEN AT
KRISTENSEN HI
BAK H
EZBAN M
HEDNER U
Citation: J. Holst et al., LOCAL APPLICATION OF ACTIVE-SITE INHIBITED FACTOR VIIA SIGNIFICANTLY REDUCES THROMBUS WEIGHT AND IMPROVES PATENCY IN A VENOUS EXPERIMENTAL THROMBOSIS MODEL, Thrombosis and haemostasis, 1997, pp. 2804-2804
Authors:
KRISTENSEN AT
EZBAN M
VILLUMSEN A
GROES L
ELM T
HEDNER U
Citation: At. Kristensen et al., THE EFFECT OF SIMULTANEOUS ADMINISTRATION OF ASPIRIN, HEPARIN, AND THE FFR-CK-ACTIVE-SITE INHIBITED RFVIIA ON NAIL CUTICLE BLEEDING IN RABBITS, Thrombosis and haemostasis, 1997, pp. 2808-2808
Authors:
ARNLJOTS B
EZBAN M
HEDNER U
Citation: B. Arnljots et al., INHIBITION OF EXPERIMENTAL ARTERIAL THROMBOSIS BY LOCAL APPLICATION OF ACTIVE-SITE INACTIVATED FACTOR VIIA, Thrombosis and haemostasis, 1997, pp. 2809-2809
Authors:
KJALKE M
OLIVER JA
MONROE DM
HOFFMAN M
EZBAN M
HEDNER U
ROBERTS HR
Citation: M. Kjalke et al., THE EFFECT OF ACTIVE SITE-INHIBITED FACTOR VIIA ON TISSUE FACTOR-INITIATED COAGULATION USING PLATELETS BEFORE AND AFTER ASPIRIN ADMINISTRATION, Thrombosis and haemostasis, 78(4), 1997, pp. 1202-1208